Oxygen Biotherapeutics Mission & Goals
News & Events
Oxygen Biotherapeutics Inc. Provides an Update on Communication with the FDA Regarding Oxycyte Development Program
Monday, March 31, 2014 5:30 am PDT
Public Company Information:
MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that it has received written confirmation from the Food and Drug Administration (FDA) that the clinical hold on the Oxycyte development program has been lifted. more..
The Mission of Oxygen Biotherapeutics is to develop and market specialty pharmaceutical products that address unmet needs of critical care patients, their health care providers, and the hospitals who treat these patients.